SNDX · Syndax Pharmaceuticals Inc
$19.84
+0.76 (+3.98%)
At close · Aug 14
Market Cap
$1.77B
Shares
89.30M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
7,200,000 shares
as of 2026-01-01
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-05 | — | $200,000,000 | $157,900,000 as of 2026-06-30 | — | 10-Q , filed 2026-08-04 |
Key facts
CIK
1395937
CUSIP
87164F105
13F (30d)
233 filings
227 filers
Visit website
Investor relations